glp-1 treatment monroe and Anesthesia: Considerations and Cautions for CRNAs GLP-1 Microdosing – Kora MD

Clinical use: Supervised protocols at medical clinics involve subcutaneous injection over 4 to 8 weeks, with dosing individualized to injury type and severity

[17] Current evidence suggests that if GLP-1-associated gastroparesis occurs, it remains an uncommon complication, though ongoing surveillance continues to refine our understanding of this potential risk

Consulting a healthcare provider for individualized recommendations adds structure and makes the plan more sustainable

Citations Citations to this article as recorded by Diabetes Fact Sheet 2025: Special Edition on Diabetes with Obesity and in Pregnancy Se Eun Park, Se Hee Min, Jin Hwa Kim, Seung-Hwan Lee, Han Na Jung, Joon Ho Moon, Kyungdo Han, Seung-Hyun Ko, Bong Soo Cha, Sung Hee Choi Diabetes & Metabolism Journal.2026